Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Informed Consent Issues Proving Tricky In CMS Evidence-Development Policy

This article was originally published in The Gray Sheet

Executive Summary

Issues surrounding informed consent appear to be complicating CMS' efforts to finalize a policy allowing it to require evidence collection as a condition of national Medicare coverage
Advertisement

Related Content

Informed Consent Debate Resurfaces Over Medicare Coverage With Evidence Development
CMS Offers Two Paths To “Coverage With Evidence” In Revised Guidance
Imaging Registry Begins: Coverage-With-Evidence Policy Gets A Second Wind
AdvaMed Medicare Conference In Brief
AHRQ Works To Complete Patient Registry Reference Guide
Coverage With Evidence Development Won’t Go Far – Former CMS Staffer
Coverage With Evidence Development: Planning For Reimbursement On CMS’ Shifting Playing Field
Coverage With Evidence Development: Planning For Reimbursement On CMS’ Shifting Playing Field
Bariatric Surgery National Coverage Could Be Subject To CED – Phurrough
CMS To Help Build National FDG-PET Cancer Registry, Will Cover Trials
Advertisement
UsernamePublicRestriction

Register

MT023338

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel